These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28281245)

  • 1. Medicare modernization and diffusion of endoscopy in FFS medicare.
    Mobley LR; Amaral P; Kuo TM; Zhou M; Bose S
    Health Econ Rev; 2017 Dec; 7(1):13. PubMed ID: 28281245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Happened to Disparities in CRC Screening Among FFS Medicare Enrollees Following Medicare Modernization?
    Mobley LR; Kuo TM; Zhou M; Rutherford Y; Meador S; Koschinsky J
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):273-291. PubMed ID: 30232793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macro-level factors impacting geographic disparities in cancer screening.
    Mobley LR; Kuo TM; Traczynski J; Udalova V; Frech HE
    Health Econ Rev; 2014 Dec; 4(1):13. PubMed ID: 26054402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managed care and the diffusion of endoscopy in fee-for-service Medicare.
    Mobley LR; Subramanian S; Koschinsky J; Frech HE; Trantham LC; Anselin L
    Health Serv Res; 2011 Dec; 46(6pt1):1905-27. PubMed ID: 22092022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of preventive services by Medicare fee-for-service beneficiaries: does spillover from managed care matter?
    Koroukian SM; Litaker D; Dor A; Cooper GS
    Med Care; 2005 May; 43(5):445-52. PubMed ID: 15838408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of performance of traditional Medicare vs Medicare managed care.
    Landon BE; Zaslavsky AM; Bernard SL; Cioffi MJ; Cleary PD
    JAMA; 2004 Apr; 291(14):1744-52. PubMed ID: 15082702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring access to effective care among elderly medicare enrollees in managed and Fee-for-Service care: a retrospective cohort study.
    Barton MB; Dayhoff DA; Soumerai SB; Rosenbach ML; Fletcher RH
    BMC Health Serv Res; 2001; 1():11. PubMed ID: 11716798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Did changes in drug reimbursement after the medicare modernization act affect chemotherapy prescribing?
    Hornbrook MC; Malin J; Weeks JC; Makgoeng SB; Keating NL; Potosky AL
    J Clin Oncol; 2014 Dec; 32(36):4042-9. PubMed ID: 25267762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing post-acute rehabilitation use, length of stay, and outcomes experienced by Medicare fee-for-service and Medicare Advantage beneficiaries with hip fracture in the United States: A secondary analysis of administrative data.
    Kumar A; Rahman M; Trivedi AN; Resnik L; Gozalo P; Mor V
    PLoS Med; 2018 Jun; 15(6):e1002592. PubMed ID: 29944655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization.
    Xu WY; Wickizer TM; Jung JK
    BMC Health Serv Res; 2019 Jun; 19(1):392. PubMed ID: 31208422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing mortality and time until death for medicare HMO and FFS beneficiaries.
    Maciejewski ML; Dowd B; Call KT; Feldman R
    Health Serv Res; 2001 Feb; 35(6):1245-65. PubMed ID: 11221818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare Managed Care Spillovers and Treatment Intensity.
    Callison K
    Health Econ; 2016 Jul; 25(7):873-87. PubMed ID: 25960418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of HMOs on the inpatient utilization of medicare beneficiaries.
    Dhanani N; O'Leary JF; Keeler E; Bamezai A; Melnick G
    Health Serv Res; 2004 Oct; 39(5):1607-27. PubMed ID: 15333125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Completeness of cohort-linked U.S. Medicare data: An example from the Agricultural Health Study (1999-2016).
    Parks CG; Shrestha S; Long S; Flottemesch T; Woodruff S; Chen H; Andreotti G; Hofmann JN; Beane Freeman LE; Sandler DP
    Prev Med Rep; 2022 Jun; 27():101766. PubMed ID: 35369114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between managed care insurance and use of lower-mortality hospitals for CABG surgery.
    Erickson LC; Torchiana DF; Schneider EC; Newburger JW; Hannan EL
    JAMA; 2000 Apr; 283(15):1976-82. PubMed ID: 10789665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospice use among Medicare managed care and fee-for-service patients dying with cancer.
    McCarthy EP; Burns RB; Ngo-Metzger Q; Davis RB; Phillips RS
    JAMA; 2003 May; 289(17):2238-45. PubMed ID: 12734135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospice use in Medicare managed care and fee-for-service systems.
    Virnig BA; Fisher ES; McBean AM; Kind S
    Am J Manag Care; 2001 Aug; 7(8):777-86. PubMed ID: 11519237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.